Fig. 2.
Percentages of patients who achieved Assessment of SpondyloArthritis international society working group criteria (ASAS)5/6, ASAS40, and ASAS partial remission responses following 12 and 60 weeks of adalimumab therapy
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.